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Introduction & Objectives: In Spain kidneys after controlled cardiac death (cDCD) has increased over the years. This group present a high
incidence of DGF. Graft quality optimization has been the major interest over the last decade. The aim of this study is to evaluate de benefit of
hypothermic machine perfusion (HMP) in reducing de delayed graft function (DGF) and primary non-function (PNF) compared to cold storage in
cDCD. Other parameters are evaluated: 99mTc-MAG-3 scintigraphy TFS (tubular function slope) and ultrasound (US) resistive index (RI) 24-48
hours after surgery, rejection rate, duration of DGF.
Materials & Methods: We are conducting a randomized prospective study since April 2017. We select all cDCD from one single institution, Hospital
Universitari de Bellvitge, and we randomize 1:1 to cold storage and HMP. Data from donors, surgery, HMP, and post-operatory are collected; and
analysed.
Results: Since April 2017 until September 2019, there were 22 valid donors enter in the study, 44 kidneys transplants had been made from those
donors. Donors mean age was 60 (CI 95% 57-64), mean functional warm ischemia time was 20 min (CI 95% 16-23). Two kidneys need to be
switch in randomization because of polar artery. Comparative analysis shows a beneficial effect of the HMP in reduce DGF and fDGF, p=0.042 and
p=0.016. Comparative data are showed in Table 2. We did not have PNF.
Comparative Data (Table 2)
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Machine Perfusion (22) Cold storage (22) p
Receptor Age (Years) 59 (IC95%: 53 - 64) 58 (IC95%: 54- 63) 0.9494









Cold ischemia time CIT (min) Median (IQR) 575 (505-815) 304 (266-436) 0.000
Rejection (biopsy confirmation) 9% (2) 14% (3) 1.000








fDGF (absence of the decrease in serum creatinine










4 (2-13) 9 (5-12) 0.431
Number of dialysis
Mean (CI95%)































*We exclude the rejection case for the analysis.
Conclusions: Hypothermic Machine perfusion preservation seem to produce a beneficial effect in order to reduce de DGF and fDGF, despite de
difference in CIT between groups.
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